Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Precision BioSciences, Inc. (DTIL : NSDQ)
 
 • Company Description   
Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products primarily in the United States. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. Precision BioSciences Inc. is based in Durham, North Carolina.

Number of Employees: 108

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.20 Daily Weekly Monthly
20 Day Moving Average: 528,290 shares
Shares Outstanding: 11.09 (millions)
Market Capitalization: $46.57 (millions)
Beta: 1.43
52 Week High: $11.09
52 Week Low: $3.61
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -16.67% -20.28%
12 Week -4.55% -22.12%
Year To Date 10.24% 4.49%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
302 EAST PETTIGREW STREET SUITE A-100
-
DURHAM,NC 27701
USA
ph: 919-314-5512
fax: -
ir@precisionbiosciences.com http://www.precisionbiosciences.com
 
 • General Corporate Information   
Officers
Michael Amoroso - President; Chief Executive Officer and Director
Kevin Buehler - Chairman and Director
John Alexander Kelly - Chief Financial Officer
Melinda Brown - Director
Stanley Frankel - Director

Peer Information
Precision BioSciences, Inc. (CORR.)
Precision BioSciences, Inc. (RSPI)
Precision BioSciences, Inc. (CGXP)
Precision BioSciences, Inc. (BGEN)
Precision BioSciences, Inc. (GTBP)
Precision BioSciences, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 74019P207
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/07/25
Share - Related Items
Shares Outstanding: 11.09
Most Recent Split Date: 2.00 (0.03:1)
Beta: 1.43
Market Capitalization: $46.57 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.09 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.77 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/07/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.90
Price/Cash Flow: -
Price / Sales: 0.91
EPS Growth
vs. Year Ago Period: -531.43%
vs. Previous Quarter: 30.94%
Sales Growth
vs. Year Ago Period: -99.84%
vs. Previous Quarter: -95.45%
ROE
06/30/25 - -
03/31/25 - -69.26
12/31/24 - -40.67
ROA
06/30/25 - -
03/31/25 - -29.30
12/31/24 - -14.81
Current Ratio
06/30/25 - -
03/31/25 - 6.62
12/31/24 - 6.34
Quick Ratio
06/30/25 - -
03/31/25 - 6.62
12/31/24 - 6.34
Operating Margin
06/30/25 - -
03/31/25 - -83.06
12/31/24 - -34.51
Net Margin
06/30/25 - -
03/31/25 - -42.99
12/31/24 - 10.43
Pre-Tax Margin
06/30/25 - -
03/31/25 - -42.99
12/31/24 - 10.43
Book Value
06/30/25 - -
03/31/25 - 4.68
12/31/24 - 6.87
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.45
12/31/24 - 0.40
Debt-to-Capital
06/30/25 - -
03/31/25 - 31.17
12/31/24 - 28.36
 

Powered by Zacks Investment Research ©